Stomach Cancer Trial, Recruiting NCT04024917 Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04024917
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with cancer that has spread to the lining of the abdomen (peritoneal carcinosis) and are waiting for a type of surgery to remove it (cytoreductive surgery)
  • You scored above 3 on an anxiety or psychological distress scale, meaning you are experiencing a notable level of anxiety or emotional distress
  • You are able to speak and understand French well enough to participate
  • You are registered with the French social security system
  • You are staying at the Institute of Cancer of Montpellier the day before your surgery
  • You are willing and able to sign a consent form before any trial activities begin

Who may not be able to join:

  • You already regularly practice cardiac coherence (a specific breathing and relaxation technique) in your daily life
  • You have a diagnosed psychiatric condition such as psychosis, bipolar disorder, intellectual disability, learning disabilities, or ADHD — note that emotional distress directly related to your illness does not exclude you (confirm with trial site)
  • You are unable to complete questionnaires due to physical or sensory difficulties
  • You have had a heart transplant or bypass surgery within the last year before your scheduled surgery
  • You have had an uncontrolled neurological condition (a disorder affecting the brain or nervous system) in the last 6 months
  • You have had a dependency on mind-altering substances (not including smoking) in the last 6 months
  • You have cancer that has spread to the brain
  • You have a naturally slow heart rate of 50 beats per minute or fewer (confirm with trial site)
  • You are currently taking medications called beta-blockers
  • You currently have an irregular heartbeat (cardiac arrhythmia)
  • You have severe heart failure where your heart is pumping less than 40% of its normal capacity
  • You have ongoing, uncontrolled chronic pain that would make it hard to practice the relaxation technique used in this trial
  • You have chronic obstructive pulmonary disease (a long-term lung condition that makes breathing difficult)
  • You are legally under guardianship or a similar form of legal protection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Estelle Guerdoux-Ninot, MD, Institut régional du cancer de Montpellier

Phone: 4 67 61 31 02

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Registry
ClinicalTrials.gov
Start date
21 September 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Cardiac Coherence Program Adherence Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov